The University of California, San Francisco (UCSF), experience with topical carmustine (BCNU) in the treatment of approximately 200 patients with mycosis fungoides (MF) is summarized. Topical BCNU is an effective treatment for patch- and early plaque-stage MF. Side-effects are usually not a major deterrent to continuation of therapy.
No takes yet. Share an insight, caveat, or question.
Herschel S. Zackheim (2003) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: